Anxiety and depression in patients with histiocytic neoplasms and their associated clinical features.

ABSTRACT:

Abstract

Anxiety and depression are common in many cancers but, to our knowledge, have not been systematically studied in patients with histiocytic neoplasms (HNs). We sought to estimate rates of anxiety and depression and identify clinical features and patient-reported outcomes (PROs) associated with anxiety and depression in patients with HNs. A registry-based cohort of patients with HNs completing PROs including the hospital anxiety and depression scale (HADS) from 2018 to 2023 was identified. Moderate or severe anxiety or depression were respectively defined as a score of ≥11 on the HADS anxiety or depression subscales. Associations of variables, including other validated PROs, with moderate or severe anxiety or depression were modeled with logistic regression to estimate odds

SUBMITTER: Reiner AS 

PROVIDER: S-EPMC11957516 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature